Trial intelligence / Profile preview

Etonogestrel contraceptive implant non-radiopaque postmarketing safety study in Chinese women

CTR20160241Phase 4Completed

Sponsor
Organon & Co.
Start
Apr 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of etonogestrel in contraception, sponsored by Organon & Co.. Started Apr 2016; status: completed.

02

Drugs

etonogestrel
03

Conditions

contraception

Beyond the preview

Go deeper on CTR20160241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call